CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice

被引:222
作者
Weber, Christian [1 ,2 ,3 ]
Meiler, Svenja [3 ,4 ]
Doering, Yvonne [1 ,6 ]
Koch, Miriam [4 ]
Drechsler, Maik [3 ,4 ]
Megens, Remco T. A. [1 ,3 ,7 ]
Rowinska, Zuzanna [3 ,5 ]
Bidzhekov, Kiril [1 ,3 ]
Fecher, Caroline [4 ]
Ribechini, Eliana [8 ]
van Zandvoort, Marc A. M. J. [2 ,3 ]
Binder, Christoph J. [9 ,10 ]
Jelinek, Ivett [6 ]
Hristov, Mihail [1 ,3 ]
Boon, Louis [11 ]
Jung, Steffen [12 ]
Korn, Thomas [13 ]
Lutz, Manfred B. [8 ]
Foerster, Irmgard [14 ]
Zenke, Martin [6 ]
Hieronymus, Thomas [6 ]
Junt, Tobias [15 ]
Zernecke, Alma [2 ,4 ]
机构
[1] Univ Munich, Inst Cardiovasc Prevent, D-80336 Munich, Germany
[2] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands
[3] Rhein Westfal TH Aachen, Fac Med, Inst Mol Cardiovasc Res IMCAR, Aachen, Germany
[4] Univ Wurzburg, Rudolf Virchow Zentrum, DFG Res Ctr Expt Med, D-97080 Wurzburg, Germany
[5] Rhein Westfal TH Aachen, Univ Hosp, European Vasc Ctr Aachen Maastricht, Aachen, Germany
[6] Rhein Westfal TH Aachen, Dept Cell Biol, Inst Biomed Engn, Aachen, Germany
[7] Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res, Aachen, Germany
[8] Univ Wurzburg, Inst Virol & Immunbiol, D-97080 Wurzburg, Germany
[9] Med Univ Vienna, Dept Lab Med, Vienna, Austria
[10] Med Univ Vienna, Austrian Acad Sci, Ctr Mol Med CeMM, Vienna, Austria
[11] Bioceros BV, Utrecht, Netherlands
[12] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
[13] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-8000 Munich, Germany
[14] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany
[15] Novartis Pharma AG, Basel, Switzerland
关键词
MACROPHAGE-DERIVED CHEMOKINE; LOW-DENSITY-LIPOPROTEIN; DEFICIENT MICE; IN-VIVO; ARTERIAL INTIMA; STEADY-STATE; ACTIVATION; RECEPTORS; INFLAMMATION; EXPRESSION;
D O I
10.1172/JCI44925
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Immune mechanisms are known to control the pathogenesis of atherosclerosis. However, the exact role of DCs, which are essential for priming of immune responses, remains elusive. We have shown here that the DC-derived chemokine CCL17 is present in advanced human and mouse atherosclerosis and that CCL17(+) DCs accumulate in atherosclerotic lesions. In atherosclerosis-prone mice, Ccl17 deficiency entailed a reduction of atherosclerosis, which was dependent on Tregs. Expression of CCL17 by DCs limited the expansion of Tregs by restricting their maintenance and precipitated atherosclerosis in a mechanism conferred by T cells. Conversely, a blocking antibody specific for CCL17 expanded Tregs and reduced atheroprogression. Our data identify DC-derived CCL17 as a central regulator of Treg homeostasis, implicate DCs and their effector functions in atherogenesis, and suggest that CCL17 might be a target for vascular therapy.
引用
收藏
页码:2898 / 2910
页数:13
相关论文
共 70 条
[1]   Natural regulatory T cells control the development of atherosclerosis in mice [J].
Ait-Oufella, H ;
Salomon, BL ;
Potteaux, S ;
Robertson, AKL ;
Gourdy, P ;
Zoll, J ;
Merval, R ;
Esposito, B ;
Cohen, JL ;
Fisson, S ;
Flavell, RA ;
Hansson, GK ;
Klatzmann, D ;
Tedgui, A ;
Mallat, Z .
NATURE MEDICINE, 2006, 12 (02) :178-180
[2]   Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment? [J].
Alderman, CJJ ;
Bunyard, PR ;
Chain, BM ;
Foreman, JC ;
Leake, DS ;
Katz, DR .
CARDIOVASCULAR RESEARCH, 2002, 55 (04) :806-819
[3]   Compartmentalized production of CCL17 in vivo:: Strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen [J].
Alferink, J ;
Lieberam, I ;
Reindl, W ;
Behrens, A ;
Weiss, S ;
Hüser, N ;
Gerauer, K ;
Ross, R ;
Reske-Kunz, AB ;
Ahmad-Nejad, P ;
Wagner, H ;
Förster, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (05) :585-599
[4]   C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential [J].
Andrew, DP ;
Ruffing, N ;
Kim, CH ;
Miao, WY ;
Heath, H ;
Li, Y ;
Murphy, K ;
Campbell, JJ ;
Butcher, EC ;
Wu, LJ .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :103-111
[5]   Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization [J].
Angeli, V ;
Llodrá, J ;
Rong, JX ;
Satoh, K ;
Ishii, S ;
Shimizu, T ;
Fisher, EA ;
Randolph, GJ .
IMMUNITY, 2004, 21 (04) :561-574
[6]   MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment [J].
Bernhagen, Juergen ;
Krohn, Regina ;
Lue, Hongqi ;
Gregory, Julia L. ;
Zernecke, Alma ;
Koenen, Rory R. ;
Dewor, Manfred ;
Georgiev, Ivan ;
Schober, Andreas ;
Leng, Lin ;
Kooistra, Teake ;
Fingerle-Rowson, Guenter ;
Ghezzi, Pietro ;
Kleemann, Robert ;
McColl, Shaun R. ;
Bucala, Richard ;
Hickey, Michael J. ;
Weber, Christian .
NATURE MEDICINE, 2007, 13 (05) :587-596
[7]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[8]   IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis [J].
Binder, CJ ;
Hartvigsen, K ;
Chang, MK ;
Miller, M ;
Broide, D ;
Palinski, W ;
Curtiss, LK ;
Corr, M ;
Witztum, JL .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (03) :427-437
[9]   Lack of Conventional Dendritic Cells Is Compatible with Normal Development and T Cell Homeostasis, but Causes Myeloid Proliferative Syndrome [J].
Birnberg, Tal ;
Bar-On, Liat ;
Sapoznikov, Anita ;
Caton, Michele L. ;
Cervantes-Barragan, Luisa ;
Makia, Divine ;
Krauthgamer, Rita ;
Brenner, Ori ;
Ludewig, Burkhard ;
Brockschnieder, Damian ;
Riethmacher, Dieter ;
Reizis, Boris ;
Jung, Steffen .
IMMUNITY, 2008, 29 (06) :986-997
[10]   Dendritic cells in atherosclerosis: current status of the problem and clinical relevance [J].
Bobryshev, YV .
EUROPEAN HEART JOURNAL, 2005, 26 (17) :1700-1704